Distribution studies suggest that substance P is a transmitter released by nociceptive primary afferentfibres. Acceptance of this role, however, needs more electro-physiological comparisons of the effects of substance P and the transmitter released by primary afferents on the membrane properties of dorsal horn neurones. The transmission of impulses from nociceptive afferents to supraspinal areas is subject to inhibition of both segmental and supraspinal origin. Segmental inhibition probably involves glycine and y-aminobutyric acid as transmitters. Of supraspinal inhibitions investigated in the cat none have been shown to involve amino acids, enkephalins or 5-hydroxytryptamine but there is evidence to suggest a role for noradrenaline.
Transmitters Released by Primary Afferents Relaying Nociceptive Information from the Periphery
Substance P may be a transmitter released by unmyelinated primary afferents conveying nociceptive information. Substance P is contained within small diameter primary afferent neurones l ,2 and accumulates on the distal side of a ligature of the dorsal roots indicating a transport towards the central terminals of these fibres. 3 Substance P is also contained within the peripheral processes of certain primary afferents. 2 Even if substance P is a transmitter released by central terminals, its role in peripheral terminals remains obscure since the transduction of incident energy to the firing of nociceptive fibres is not considered to involve a chemical mediator. This may not be true of all peripheral transduction since the presence of vesicles in mechanoreceptor cells such as Merkel's discs is well documented. 4 Within the spinal cord, substance P is most concentrated in the upper layers of dorsal horn, lamina I and the underlying substantia gelatinosa. These areas are the major sites of termination of nociceptive afferents. 5 ,6 There is an additional plexus of substance P containing fibres in the deeper laminae V and VI and around the central cana1. 2 Sectioning of dorsal roots produces a large decrease in the levels of substance P in these laminae. These distribution studies make a convincing association between substance P and nociceptive primary afferents. Capsaicin (derived from red peppers) injected into neonatal rats induced a loss of small diameter primary afferent neurones 7 and approximately a 50070 drop in substance P levels in the dorsal horn. 8 If substance P is a transmitter released by nociceptive afferents then capsaicin treatment should affect pain perception. The reactions of capsaicin-treated rats to noxious cutaneous stimuli, however, have not been uniform. One group found these rats to be analgesic when using thermal stimuli 9 whereas others have reported analgesia to mechanical but not thermal noxious stimuli 10 suggesting a transmitter other than substance P for the latter. A disquieting finding for the assumption that the presence of substance P in primary afferents indicates a transmitter role is that while sciatic nerve section produced a reduction in the substance P levels of the dorsal horn, transmission of impulses in nociceptive primary afferents was apparently unimpaired.
When administered electrophoretically from micropipettes near single dorsal horn neurones, substance P has excited neurones but compared to amino acid excitants, such as L-glutamate, the effects have not been striking. 11 ,12 Typically, excitation by substance P has been of delayed onset and offset but this may be an artefact of delayed electrophoretic release from glass pipettes. An association between excitation by substance P and by noxious heating of the skin has been reported for dorsal horn neurones 1 1 but the significance of this is obscure since it was not known if the cells studied were monoor polysynaptically activated by impulses in primary afferents, and hence sensitivity to substance P could relate as well to terminals of dorsal horn inter-neurones as to unmyelinated primary afferents. In addition, these findings do not correlate with the report that capsaicin treatment, which reduced substance P in the dorsal horn, did not impair sensitivity to noxious thermal stimuli. 10 Radioimmunoassay of substance P in perfusates of the surface of the spinal cord has permitted studies of the spinal release of substance P following peripheral nerve stimulation. Using stimulus amplitudes adequate to excite large myelinated fibres of the rat no release of substance P over basal levels was detected.13 When unmyelinated fibres were stimulated a thirty-fold increase occurred. It was also observed that the intra-peritoneal administration of capsaicin (a very painful procedure) gave a massive release of substance P.
Collectively the case is very suggestive that substance P is released by impulses in small diameter primary afferents and as such may well be a transmitter. The co-existence of substance P with other substances in central fibres has been described and thus there remains the possibility that nerve terminals may release a variety of substances in response to invading impulses and that perhaps not all of these produce changes in post-synaptic membrane consistent with a fast acting transmitter. There is thus considerable room for speculation on the function of released substances but a relative deficit of experimental facts. Until more data is forthcoming on the changes in the postsynaptic membrane of dorsal horn neurones induced by both substance P and by unmyelinated primary afferents, it is perhaps best to reserve judgement on whether substance P is a transmitter or plays some other role in the function of primary afferent fibres. An antagonist of the action of substance P on dorsal horn neurones would help immensely.
Other Pep tides in Primary Afferent Neurones
These are merely listed since the functional significance of the variety of peptides occurring in dorsal root fibres is quite unknown. By immunohistochemical techniques the following polypeptides have been demonstrated in dorsal root fibres: somatostatin, cholecystokinin, neurotensin, vasoactive intestinal polypeptide.
Amino Acids
Although there is evidence that L-glutamate is a transmitter released by primary afferent fibres,15,16 whether this amino acid is released by terminals of unmyelinated nociceptive primary afferents is unknown.
Inhibitory Transmitters and the Spinal Transmission of Nociceptive Information
Spinal inhibition can be divided into two main types: that generated locally within the spinal cord or segmental inhibition and that produced by activity in long descending supraspinal fibres. Supraspinal inhibition could result from activation of spinal inhibitory interneurones and thus could ultimately involve the same mechanisms as segmental inhibition but there is pharmacological evidence that this is not so.
The two amino acids glycine and y-aminobutyric acid (GAB A) are known to be mediators of some segmental inhibitions l7 ,18 but their involvement with transmission of nociceptive afferents is not known. An example of segmental inhibition of pain is the well known inhibition of excitation of a dorsal horn neurone by nociceptive afferents by preceding impulses in large myelinated afferents. 19 It is easy to demonstrate that this is not dependent upon supraspinal pathways but the intraspinal circuitry is not known. This inhibition was an important component of the gate control theory.2o. It could involve release of GABA at presynaptic sites and of GABA and glycine at somatic inhibitory synapses but it has not been adequately investigated pharmacologically. Enkephalins are not involved as this inhibition is not influenced by naloxone (Headley and Duggan, unpublished) . Acupuncture could be mediated by segmental inhibition and one report did suggest the involvement of glycine and GABA but this has not been further investigated. The one group that found good selective inhibition of dorsal horn neurones by acupuncture was reduced by naloxone, did not favour a segmental process but rather a release of endorphins from the pituitary.21
Enkephalins
It is now nearly six years since Hughes 22 described morphine-like activity in a brain extract. This activity was found to be due to two pentapeptides, methionine and leucine enkephalin. A vast number of publications has followed on the synthesis and distribution of the enkephalins and the large related peptides, the endorphins, and it is not intended to review this literature here. This discussion will be restricted to the question, what neurophysiological evidence is there that the enkephalins act as transmitters in the control of the transmission of nociceptive information? Experiments have shown that enkephalins administered from micropipettes depress the excitation of dorsal horn neurones by noxious cutaneous stimuli. 23
If enkephalins are tonically released near spinal neurones then administration of an opiate antagonist such as naloxone should change the firing rate of the relevant neurones. There are such reports in both cat2 4 and rat2 5 but others have failed to observe consistent effects by naloxone. 26 In my laboratory, naloxone administration has usually had no effect on the firing of dorsal horn neurones of anaesthetised or decerebrate cats, but rarely large increases in firing have been observed. If the latter does reflect tonic release of enkephalins, the conditions necessary to produce this have not been adequately defined. There is, of course, a large but conflicting literature dealing with the effect of naloxone in behavioural experiments and this will not be reviewed here. Suffice to say that in neurophysiological experiments dealing with anaesthetised animals, the effects of naloxone are varied and difficult to explain.
If enkephalins are important in controlling transmission of nociceptive information in the spinal cord then this might occur by descending impulses exciting neurones of the substantia gelatinosa, some of which have been shown to contain enkephalinY Tonically descending inhibition of dorsal horn neurones is present in the cat and this inhibition relatively selectively reduced the excitation of these neurones by noxious cutaneous stimuli. 26 This inhibition can be measured by reversibly cooling a segment of the spinal cord cephalic to the recording site. In the anaesthetised cat descending inhibition measured in this way was uninfluenced by naloxone administration. 26 Inhibition of the nociceptive responses of dorsal horn neurones can also be produced by electrical stimulation in the periaqueductal grey matter and near the raphe nuclei of the medulla and these sites are well known as areas which produce behavioural analgesia in both cats and rats when electrically stimulated. In the anaesthetised cat naloxone (0.1-1.0 mg/kg) had no effect on the inhibition of dorsal horn neurones produced by electrical stimulation near both the periaqueductal grey matter and medullary raphe magnus. 28 In the rat, naloxone reduced inhibition of dorsal horn neurones produced by electrical stimulation near the nucleus raphe magnus. 25 This observation needs to be confirmed since it stands in contrast to results obtained in the cat.
The mechanism of inhibition by enkephalins has been subject to recent investigation. Earlier work assumed that morphine and enkephalins acted at one receptor. There were differences but these were not considered significantY Binding techniques, however, have shown differences between enkephalin and morphinepreferring receptor sites 29 and it is now clear that in the dorsal horn different receptors occur and are probably located on different structures. 30 Thus when using microelectrodes, one to record from a lamina IV or V dorsal horn neurone and the other to administer drugs electrophoretically at known distances dorsal to the cell body, morphine reduced nociceptive responses only when administered in the substantia gelatinosa. Ventral to this area and close to the body, morphine was without effect. By contrast, enkephalin was active in the substantia gelatinosa and at all sites tested down to the cell body.31 These results are most readily explained by proposing morphinepreferring receptors on the terminals of primary afferents but not on the dendrites or somata of ventral cells. Enkephalin may act at the sites for morphine but in addition enkephalin-preferring receptors may be located on dendrites and cell bodies, Electron micrographs of the distribution of en kephalin immunoreactive material supports this proposal. In laminae I and II en kephalincontaining endings make synapses with dendrites and denritic spines but rarely with primary afferents. 32 One problem in proposing a dendritic location of enkephalin-preferring synapses is, how does this produce a selective reduction of nociceptive responses of a neurone which responds to several sensory modalities? It is possible that these differing imputs are located on different processes: thus, the enkephalin receptors may be only on those dendrites receiving nociceptive information.
The supraspinal interpretation of impulses transmitted by such a polymodal neurone could thus be varied according to the descending inhibition present. This is another possible means of suppressing the perception of pain.
Amino Acids
Although both glycine and GAB A are important inhibitory transmitters in the spinal cord, relatively few experiments have been performed on the roles of these amino acids in the transmission of nociceptive information. The involvement of glycine and GABA in particular pathways largely derives from antagonism of a particular synaptic event by strychnine (a glycine antagonist l7 ) or bicuculline (a GABA antagoniseS).
There is no study of the role of glycine and GABA in segmental inhibition of dorsal horn neurones excited by noxious cutaneous stimuli. Supraspinal inhibition has been more extensively investigated but no evidence has been obtained to implicate the inhibitory amino acids. In experiments in which tonic descending inhibition of the nociceptive responses of lumbar dorsal horn neurones was measured by intermittent cold block of the lower thoracic spinal cord, the administration of bicuculline, and/or strychnine, failed to reduce the inhibition. 32 The drugs were given either intravenously or electrophoretically from micropipettes near the bodies of neurones or at superficial sites up to and including the substantia gelatinosa.
5-Hydroxytryptamine
There is a vast literature based on drugs which interfere with 5-hydroxytryptamine (5-HT) synthesis, uptake of 5-HT into terminals or which destroy 5-HT containing neurones and which concludes that 5-HT has a role in normal processing of nociceptive information and in morphine analgesia. 34 ,35 Indeed, it is an attractive hypothesis that 5-HT is released from the terminals of raphe spinal fibres and inhibits pain transmission at or near the first synapse in the spinal cord. Neurophysiological experiments however, have not given much support to this hypothesis.
Administered from micro pipettes either in the substantia gelatinosa or near the bodies of dorsal horn neurones, 5-HT inhibited the nociceptive responses of dorsal horn neurones 4nae.sfhcslU and hlfemivc larc, Vol. X, .!\io. 2, /\,.fa.v, 1982 of the cat. 36 Intrathecal 5-HT produced analgesia in the rat. 37 In both experimental situations, methysergide antagonised the action of 5-HT but this substance has had no convincing effect on spinal inhibition.
Methysergide did not reduce tonic descending inhibition of dorsal horn neurones of the rat nor that produced by electrical stimulation near the raphe. 3R In addition, large midline lesions of the medulla of the cat did not reduce tonic descending inhibition (Hall, unpublished) . Since the cells of origin of the 5-HT containing raphe-spinal fibres were almost totally destroyed in these experiments, 5-HT can play little role in this inhibition in the cat. These experiments do not rule out a role for 5-HT in pain pathways but they do suggest that it is unlikely that this occurs in the dorsal horn.
Noradrenaline
Recent experiments have suggested that noradrenaline may be a transmitter important in the tonic control of spinal transmission of nociceptive information. Of the substances active in reducing this transmission when administered in the substantia gelatinosa, noradrenaline has been the most potent. 36 Moreover, lesions which destroy bilaterally the area of the caudal medulla which contain noradrenaline containing cells, reduce or abolish tonic descending inhibition in the cat (Hall, unpublished). Experiments of this type are relatively coarse since many other neurones are necessarily destroyed. Work on the role of noradrenaline as a transmitter in supraspinal control has been impeded by lack of a suitable antagonist. Of the Cl' and f3 adrenergic blockers tested to date, none have blocked the action of noradrenaline in the substantia gelatinosa and none have reduced supraspinal inhibition. Indeed, despite the host of potential antagonists used, supraspinal inhibition has not been reduced by pharmacological means. It is therefore possible that an as yet undescribed transmitter is involved.
